Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/23/2025

Management of Aspiration Risk in Stroke Patients

Introduction to Aspiration Risk

  • Clopidogrel (Plavix) can be safely administered to stroke patients at risk for aspiration by using alternative administration routes such as rectal administration or through an enteral tube, rather than oral tablets, according to the International Journal of Stroke guidelines 1
  • Long-term antiplatelet therapy is indicated for patients with non-cardioembolic ischemic stroke, with options including aspirin (81-325 mg daily), clopidogrel (75 mg daily), or aspirin + dipyridamole, as recommended by the International Journal of Stroke 1

Assessment and Prevention of Aspiration

  • Clinical swallowing assessment should be performed before any oral intake, as recommended by the Stroke guidelines 2
  • Patients should be kept NPO until swallowing ability is properly assessed, according to the Stroke guidelines 2
  • The bed should be elevated at least 30° when administering any medication to patients at risk of aspiration, as recommended by the Stroke guidelines 2

Alternative Administration Routes

  • Enteral tube administration: Clopidogrel 75 mg daily can be administered via enteral tube, according to the International Journal of Stroke guidelines 1
  • Alternative antiplatelet: Rectal aspirin 325 mg daily is a reasonable alternative for stroke patients with impaired swallowing, as recommended by the International Journal of Stroke guidelines 1

Monitoring and Reassessment

  • Patients should be monitored for signs of aspiration pneumonia, with regular reassessment of swallowing function to determine when oral administration can be resumed, although no specific citation is provided for this recommendation, it is implied by the context of the article and the importance of minimizing aspiration risk 1